Valuation: FDC Limited

Market Cap 53.45B 553M 494M 461M 418M 788M 794M 5.54B 2.16B 27.18B 2.07B 2.03B 87.39B P/E 2025
24.1x
P/E 2026 18.6x
Enterprise Value 48.39B 500M 447M 417M 379M 713M 719M 5.01B 1.96B 24.61B 1.88B 1.84B 79.11B EV / Sales 2025
2.8x
EV / Sales 2026 2.18x
Free-Float
30.06%
Yield 2025
1.27%
Yield 2026 1.56%
1 day-1.37%
1 week-4.52%
Current month-4.52%
1 month-5.29%
3 months-23.96%
6 months-4.47%
Current year-23.41%
1 week 321.4
Extreme 321.4
342.85
1 month 321.4
Extreme 321.4
365.6
Current year 312.95
Extreme 312.95
442
1 year 312.95
Extreme 312.95
473.6
3 years 312.95
Extreme 312.95
658.85
5 years 225
Extreme 225
658.85
10 years 148.3
Extreme 148.3
658.85
Manager TitleAgeSince
Chief Executive Officer 90 18/11/2009
Chief Executive Officer 63 30/09/1993
Director of Finance/CFO - 23/10/2025
Director TitleAgeSince
Director/Board Member 48 31/12/2001
Director/Board Member 63 30/09/1993
Chairman 90 31/03/2026
Change 5-day change 1-year change 3-year change Capi.($)
-1.37%-4.52% - - 553M
+2.70%+2.73%+40.91%+110.31% 1,060B
+1.44%-2.38%+36.83%+63.95% 623B
+1.75%+3.73%+16.55%+83.05% 480B
+0.60%-1.73%+62.98%+37.46% 352B
-1.92%+1.46%+21.56%+41.16% 345B
-1.51%+0.36%+11.25%+34.44% 274B
-1.14%-1.79%-5.63%+11.10% 249B
+2.60%-2.00%+39.77%+54.44% 223B
+1.82%-1.48%+25.75%+96.48% 182B
Average -0.41%-0.48%+27.77%+59.15% 420.89B
Weighted average by Cap. -0.33%+0.04%+31.44%+70.19%

Financials

2025 2026
Net sales 21.08B 218M 195M 182M 165M 311M 313M 2.18B 853M 10.72B 818M 800M 34.47B 21.71B 224M 201M 187M 170M 320M 322M 2.25B 878M 11.04B 843M 824M 35.49B
Net income 2.67B 27.58M 24.64M 22.99M 20.88M 39.33M 39.62M 276M 108M 1.36B 104M 101M 4.36B 2.81B 29.09M 25.99M 24.25M 22.03M 41.49M 41.8M 291M 114M 1.43B 109M 107M 4.6B
Net Debt -5.15B -53.23M -47.56M -44.38M -40.31M -75.91M -76.48M -533M -208M -2.62B -200M -196M -8.42B -5.06B -52.31M -46.74M -43.61M -39.61M -74.6M -75.16M -524M -205M -2.57B -196M -192M -8.27B
Projected Income Statement - Annual - FDC Limited
Logo FDC Limited
FDC Limited is an India-based company, which is principally engaged in the business of manufacturing and trading of pharmaceutical products. The Company is specialized in manufacturing Oral Rehydration Solutions (ORS), energy drinks, antibiotics and ophthalmic therapies. Its products include Albuterol Sulfate, Bromhexine Hydrochloride, Cinnarizine, Flunarizine Dihydrochloride, Flurbiprofen Sodium, Miconazole Nitrate, Timolol Maleate, Amoxycillin + Clavulanic Acid, Rupatadine Fumarate, Salbutamol Sulphate, Kaolin Light/ Pectin, among others. The Company’s product offerings cover an extensive range of categories, including anti-infectives, gastrointestinal treatments, ophthalmic, vitamins, minerals, dietary supplements, cardiovascular solutions, anti-diabetics, respiratory care, gynecology, dermatology and analgesics. Its various brands include Zifi, Electral, Enerzal, Vitcofol, Pyrimon, Zocon, Zoxan, Zathrin, Zipod, Zefu, Cotaryl and Mycoderm.
Employees
7,076
Date Price Change Volume
08/10/26 ₹324.05 -1.37% 113,873
07/10/26 ₹328.55 -1.53% 84,094
06/10/26 ₹333.65 +0.71% 113,050
05/10/26 ₹331.30 -1.37% 90,007
01/10/26 ₹335.90 -1.03% 107,854
Trader
-
Investor
-
Global
-
Quality
-
ESG MSCI
B